INDIE SEMICONDUCTOR INC-A (INDI)

US45569U1016 - Common Stock

5.08  -0.4 (-7.3%)

Premarket: 4.97 -0.11 (-2.17%)

Fundamental Rating

3

Overall INDI gets a fundamental rating of 3 out of 10. We evaluated INDI against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. INDI may be in some trouble as it scores bad on both profitability and health. INDI is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

In the past year INDI has reported negative net income.
INDI had a negative operating cash flow in the past year.
INDI had negative earnings in each of the past 5 years.
INDI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of INDI (-10.30%) is worse than 72.22% of its industry peers.
INDI's Return On Equity of -17.44% is on the low side compared to the rest of the industry. INDI is outperformed by 73.15% of its industry peers.
Industry RankSector Rank
ROA -10.3%
ROE -17.44%
ROIC N/A
ROA(3y)-13.41%
ROA(5y)-82.76%
ROE(3y)-22.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 41.46%, INDI is in line with its industry, outperforming 43.52% of the companies in the same industry.
INDI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for INDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

INDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
INDI has more shares outstanding than it did 1 year ago.
INDI has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that INDI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of INDI (1.20) is worse than 69.44% of its industry peers.
INDI has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INDI (0.33) is worse than 64.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC14.14%

2.3 Liquidity

A Current Ratio of 2.66 indicates that INDI has no problem at all paying its short term obligations.
With a Current ratio value of 2.66, INDI perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
INDI has a Quick Ratio of 2.20. This indicates that INDI is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.20, INDI perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.2

7

3. Growth

3.1 Past

INDI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.08%, which is quite impressive.
Looking at the last year, INDI shows a very strong growth in Revenue. The Revenue has grown by 101.42%.
The Revenue has been growing by 114.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)101.42%
Revenue growth 3Y114.54%
Revenue growth 5YN/A
Sales Q2Q%-10.77%

3.2 Future

The Earnings Per Share is expected to grow by 49.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, INDI will show a very strong growth in Revenue. The Revenue will grow by 29.44% on average per year.
EPS Next Y-26.67%
EPS Next 2Y39.87%
EPS Next 3Y49.3%
EPS Next 5YN/A
Revenue Next Year-3.8%
Revenue Next 2Y17.32%
Revenue Next 3Y29.44%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

INDI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INDI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as INDI's earnings are expected to grow with 49.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.87%
EPS Next 3Y49.3%

0

5. Dividend

5.1 Amount

No dividends for INDI!.
Industry RankSector Rank
Dividend Yield N/A

INDIE SEMICONDUCTOR INC-A

NASDAQ:INDI (11/11/2024, 8:00:01 PM)

Premarket: 4.97 -0.11 (-2.17%)

5.08

-0.4 (-7.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.00B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.3%
ROE -17.44%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41.46%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.66
Quick Ratio 2.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-26.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)101.42%
Revenue growth 3Y114.54%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y